215 related articles for article (PubMed ID: 36030136)
1. Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment.
Jiang Y; Cheng Y; Ma S; Li T; Chen Z; Zuo X; Zhang X
J Autoimmun; 2022 Oct; 132():102887. PubMed ID: 36030136
[TBL] [Abstract][Full Text] [Related]
2. Current Understanding of Immune Thrombocytopenia: A Review of Pathogenesis and Treatment Options.
Mititelu A; Onisâi MC; Roșca A; Vlădăreanu AM
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396839
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with belimumab for immune thrombocytopenia associated with systemic lupus erythematosus: A report of two cases.
Nakayama K; Tamimoto Y; Nakayama T
Mod Rheumatol Case Rep; 2023 Dec; 8(1):69-73. PubMed ID: 37718578
[TBL] [Abstract][Full Text] [Related]
4. Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil.
Vasoo S; Thumboo J; Fong KY
Lupus; 2003; 12(8):630-2. PubMed ID: 12945723
[TBL] [Abstract][Full Text] [Related]
5. Emerging Therapies in Immune Thrombocytopenia.
Audia S; Bonnotte B
J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33801294
[TBL] [Abstract][Full Text] [Related]
6. [Advances in the Treatment of Glucocorticoid Resistance and Relapsed Immune Thrombocytopenia --Review].
Pan HM; Wen RT; Yang ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):616-620. PubMed ID: 37096545
[TBL] [Abstract][Full Text] [Related]
7. Translating mechanisms into therapeutic strategies for immune thrombocytopenia (ITP): Lessons from clinical trials.
Delshad M; Davoodi-Moghaddam Z; Pourbagheri-Sigaroodi A; Faranoush M; Abolghasemi H; Bashash D
Thromb Res; 2024 Mar; 235():125-147. PubMed ID: 38335568
[TBL] [Abstract][Full Text] [Related]
8. The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study.
Wu Q; Zhao MX; Huang XS; Lin CS; Xu Q
Lupus; 2024 May; 33(6):608-614. PubMed ID: 38518059
[TBL] [Abstract][Full Text] [Related]
9. Eltrombopag as steroid sparing therapy for immune thrombocytopenic purpura in systemic lupus erythematosus.
Maroun MC; Ososki R; Andersen JC; Dhar JP
Lupus; 2015 Jun; 24(7):746-50. PubMed ID: 25416695
[TBL] [Abstract][Full Text] [Related]
10. Investigational drugs for immune thrombocytopenia.
Provan D; Newland AC
Expert Opin Investig Drugs; 2022 Jul; 31(7):715-727. PubMed ID: 35531637
[TBL] [Abstract][Full Text] [Related]
11. Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus.
Ilizaliturri-Guerra O; Uriarte-Botello R; Pineda-Sic RÁ; Serna-Peña G; Garza-Elizondo MA; Galarza-Delgado DÁ; Leal-Bramasco AS; Elizondo-Solís CV; Santoyo-Fexas L; Villarreal-Alarcón MÁ
Rheumatol Int; 2020 Oct; 40(10):1717-1724. PubMed ID: 32797277
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of subdural hemorrhage and retinal hemorrhage in childhood-onset systemic lupus erythematosus associated with thrombocytopenia: Case report.
Wen Y; Lu P; Lu H; Hu X
Medicine (Baltimore); 2021 Jan; 100(2):e24231. PubMed ID: 33466204
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab.
Abe K; Ishikawa Y; Ishikawa J; Fujiwara M; Kita Y
Immunol Med; 2019 Dec; 42(4):185-188. PubMed ID: 31794352
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in treatments of adult immune thrombocytopenia.
Kim DS
Blood Res; 2022 Apr; 57(S1):112-119. PubMed ID: 35483935
[TBL] [Abstract][Full Text] [Related]
15. Current and emerging treatments for immune thrombocytopenia.
Dou X; Yang R
Expert Rev Hematol; 2019 Sep; 12(9):723-732. PubMed ID: 31237783
[No Abstract] [Full Text] [Related]
16. Safety and efficacy of thrombopoeitin mimetics for refractory immune thrombocytopenia purpura in patients with systemic lupus erythematosus or antiphospholipid syndrome: a case series.
Lusa A; Carlson A
Lupus; 2018 Sep; 27(10):1723-1728. PubMed ID: 29673280
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin receptor agonists and rituximab for treatment of pediatric immune thrombocytopenia: A systematic review and meta-analysis of prospective clinical trials.
Ayad N; Grace RF; Al-Samkari H
Pediatr Blood Cancer; 2022 Mar; 69(3):e29447. PubMed ID: 34962697
[TBL] [Abstract][Full Text] [Related]
18. [New treatment options for primary immune thrombocytopenia].
Gudbrandsdottir S; Frederiksen H; Birgens HS; Nielsen CH; Nielsen OJ; Stentoft J; Hasselbalch HC
Ugeskr Laeger; 2011 Jan; 173(4):271-4. PubMed ID: 21262171
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.
Gudbrandsdottir S; Frederiksen H; Hasselbalch H
Platelets; 2012; 23(6):423-9. PubMed ID: 22185370
[TBL] [Abstract][Full Text] [Related]
20. Treatment of primary and secondary immune thrombocytopenia.
Kado R; McCune WJ
Curr Opin Rheumatol; 2019 May; 31(3):213-222. PubMed ID: 30920453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
